Ruxolitinib compared with best available therapy for essential thrombocythaemia patients resistant or intolerant to hydroxycarbamide in majic: an investigator lead randomized trial

Bibliographic Details
Main Authors:	Harrison, C, Mead, A, Panchal, A, Fox, S, Yap, C, Houlton, A, Aliman, S, Wood, M, Chen, F, Coppell, J, Panoskaltsis, N, Scherber, R, Geyer, H, Dueck, A, Mesa, R, McMullin, M
Format:	Conference item
Published:	Ferrata Storti Foundation 2016

Similar Items